CoChat

Longitudinal Relationships Between Alzheimer Disease Progression and Psychosis, Depressed Mood, and Agitation/Aggression

Open access
Zahodne, Laura B., Ornstein, Katherine, Cosentino, Stephanie, Devanand, D.P., Stern, Yaakov · 2015 · The American Journal of Geriatric Psychiatry
Cited by 145

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objectives Behavioral and psychological symptoms of dementia (BPSD) are prevalent in Alzheimer’s disease (AD) and are related to poor outcomes such as nursing home placement. No study has examined the impact of individual BPSD on dependence, a clinically important feature that reflects changing patient needs and their impact on caregivers. The current study characterized independent cross-sectional and longitudinal relationships between three BPSD (i.e., psychosis, depressed mood, and agitation/aggression), cognition, and dependence to better understand the interplay between these symptoms over time. Design The Predictors Study measured changes in BPSD, cognition, and dependence in AD patients every six months. Cross-sectional and longitudinal relationships between individual BPSD, cognition, and dependence over six years were characterized using multivariate latent growth curve modeling. This approach characterizes independent changes in multiple outcome measures over time. Setting Four memory clinics in the United States and Europe. Participants 517 patients with probable Alzheimer’s disease. Measurements Columbia University Scale for Psychopathology, modified Mini-Mental State Exam, Dependence Scale. Results Both psychosis and depressed mood at study entry were associated with worse subsequent cognitive decline. Independent of cognitive decline, initial psychosis was associated with worse subsequent increases in dependence. Rates of increase in agitation/aggression separately correlated with rates of declines in both cognition and independence. Conclusions Although purely observational, findings support the poor prognosis associated with psychosis and depression in AD. Results also show that agitation/aggression tracks declines in cognition and independence independently over time. Targeted intervention for individual BPSD, particularly psychosis, could have broad impacts on not only patient well-being, but also care costs and family burden.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jagp.2013.03.014

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. Devanand, 1997, The course of psychopathologic features in mild to moderate Alzheimer disease, Arch Gen Psychiatry, 54, 257, 10.1001/archpsyc.1997.01830150083012 · DOI · Paper page
  2. Kunik, 2010, Consequences of aggressive behavior in patients with dementia, J Neurospychiatry Clin Neurosci, 22, 40, 10.1176/jnp.2010.22.1.40 · doi:10.1176/jnp.2010.22.1.40 · Paper page
  3. Knopman, 1999, Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study, Neurology, 52, 714, 10.1212/WNL.52.4.714 · DOI · Paper page
  4. Stern, 1994, Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study, Neurology, 44, 2300, 10.1212/WNL.44.12.2300 · DOI · Paper page
  5. Scarmeas, 2005, Delusions and hallucinations are associated with worse outcome in Alzheimer disease, Arch Neurol, 62, 1604, 10.1001/archneur.62.10.1601 · DOI · Paper page
  6. Winblad, 2000, Outcome measures in Alzheimer's disease: do they go far enough?, Dement Geriatr Cogn Disord, 11, 3, 10.1159/000051226 · DOI · Paper page
  7. Stern, 1994, Assessing patient dependence in Alzheimer's disease, J Gerontol, 49, M216, 10.1093/geronj/49.5.M216 · DOI · Paper page
  8. Akamigbo, 2007, New evidence of racial differences in access and their effects on the use of nursing homes among older adults, Med Care, 45, 672, 10.1097/MLR.0b013e3180455677 · DOI
  9. Cohen, 2009, Estimating dependence scale scores based on clinical dementia rating—sum of boxes scores in patients with mild cognitive impairment or mild to moderate Alzheimer's disease, Alzheimers Dement, 5, P238, 10.1016/j.jalz.2009.04.219 · doi:10.1016/j.jalz.2009.04.219
  10. Gallagher, 2011, Dependence and caregiver burden in Alzheimer's disease and mild cognitive impairment, Am J Alzheimers Dis Other Demen, 26, 110, 10.1177/1533317510394649 · DOI · Paper page
  11. Scherer, 2008, The relation of patient dependence to home health aide use in Alzheimer's disease, J Gerontol A Biol Sci Med Sci, 63, 1005, 10.1093/gerona/63.9.1005 · DOI
  12. Zhu, 2008, Patient dependence and longitudinal changes in costs of care in Alzheimer's disease, Dement Geriatr Cogn Disord, 26, 416, 10.1159/000164797 · DOI · Paper page
  13. Zhu, 2008, The effects of patient function and dependence on costs of care in Alzheimer's disease, J Am Geriatr Soc, 56, 1497, 10.1111/j.1532-5415.2008.01798.x · DOI · Paper page
  14. Stern, 1993, Multi-center study of predictors of disease course in Alzheimer's disease (the “Predictors Study”): I. Study design, cohort description and intersite comparisons, Alzheimer Dis Assoc Disord, 7, 3, 10.1097/00002093-199307010-00002 · DOI · Paper page
  15. Richards, 1993, Multi-center study of predictors of disease course in Alzheimer's disease (the ‘Predictors Study’). II. Baseline findings, Alzheimer Dis Assoc Disord, 7, 22, 10.1097/00002093-199307010-00003 · DOI · Paper page
  16. McKhann, 1984, Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  17. Stern, 1987, Modified Mini-Mental State Examination: validity and reliability, Neurology, 37, 179
  18. Folstein, 1975, ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  19. Brickman, 2001, Longitudinal assessment of patient dependence in Alzheimer disease, Arch Neurol, 59, 1304, 10.1001/archneur.59.8.1304 · DOI
  20. Devanand, 1992, The Columbia University Scale for Psychopathology in Alzheimer's disease, Arch Neurol, 49, 371, 10.1001/archneur.1992.00530280051022 · DOI · Paper page
  21. Zahodne, 2012, Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling, Neuropsychology, 26, 71, 10.1037/a0025119 · DOI
  22. Vilalta-Franch, 2013, Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality, Am J Geriatr Psychiatry, 10.1016/j.jagp.2013.01.051 · DOI
  23. Palmer, 2011, Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric symptoms on function and cognitive decline, J Alzheimers Dis, 42, 35, 10.3233/JAD-2010-101836 · DOI
  24. Buccione, 2007, Cognitive and behavioural predictors of progression rates in Alzheimer's disease, Eur J Neurol, 14, 440, 10.1111/j.1468-1331.2007.01693.x · DOI
  25. Dorenlot, 2005, Major depression as a risk factor for early institutionalization of dementia patients living in the community, Int J Geriatr Psychiatry, 20, 471, 10.1002/gps.1238 · DOI · Paper page
  26. Lopez, 1999, Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer's disease, Arch Neurol, 56, 1266, 10.1001/archneur.56.10.1266 · DOI · Paper page
  27. Farber, 2000, Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis, Arch Gen Psychiatry, 57, 1165, 10.1001/archpsyc.57.12.1165 · DOI · Paper page
  28. Sweet, 2004, Neuropathologic correlates of late onset major depression, Neuropsychopharmacology, 29, 2242, 10.1038/sj.npp.1300554 · DOI
  29. Craig, 2004, The interleukin 1 beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia, Ann Neurol, 56, 121, 10.1002/ana.20120 · DOI
  30. Go, 2005, Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses, Am J Med Genet B Neuropsychiatr Genet, 139, 28, 10.1002/ajmg.b.30219 · DOI · Paper page
  31. Meeks, 2006, The neurobiology of neuropsychiatric symptoms in dementia, Curr Opin Psychiatry, 19, 581, 10.1097/01.yco.0000245746.45384.0e · DOI · Paper page
  32. Koppel, 2012, Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis, Am J Geriatr Psychiatry, 20, 994, 10.1097/JGP.0b013e3182358921 · DOI
  33. Stern, 1995, Preliminary findings from the predictors study: utility of clinical signs for predicting disease course, Alzheimer Dis Assoc Disord, 9, S14, 10.1097/00002093-199500091-00004 · DOI
  34. Scarmeas, 2004, Motor signs during the course of Alzheimer disease, Neurology, 63, 975, 10.1212/01.WNL.0000138440.39918.0C · DOI · Paper page

Cited by

See all 145

Metadata

Authors
Zahodne, L. B., Ornstein, K., Cosentino, S., Devanand, D. P., & Stern, Y.
Venue
The American Journal of Geriatric Psychiatry
Publisher
Elsevier BV
Published
2015-02
Volume
23
Issue
2
Pages
130-140
ISSN
1064-7481 (ISSN-L)
OpenAlex
W2126128851
Cited by
145
References
10
FWCI
4.68
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Institute on Aging (AG007370, AG000261, UL1 RR024156)
  • National Center for Advancing Translational Sciences (UL1 TR000040)
  • National Center for Research Resources

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.